Paliperidone Tablet, Film Coated, Extended Release
Product Images NDC 16714-867

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 16714-867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-paliperidone-lable-1 (Spl Paliperidone Lable 1)

Spl-paliperidone-lable-1 (Spl Paliperidone Lable 1)
This is a description for Paliperidone, which is an extended-release medication that comes in a package with 30 tablets. These tablets should be swallowed whole, and not divided, crushed, or chewed. The correct dosage is once a day. The NDC number for this medication is 16714-866-01. The label is copyrighted by NorthStar Healthcare Holdings UC, and it was last updated in September 2018.*
FDA Label Image

Spl-paliperidone-lable-2 (Spl Paliperidone Lable 2)

Spl-paliperidone-lable-2 (Spl Paliperidone Lable 2)
The text provides information about a medication called Paliperidone, which comes in the form of extended-release tablets packaged in a bottle containing 30 tablets. The tablets are not to be divided, crushed, or chewed but swallowed whole, and should be taken once a day. The label indicates that this medication is produced by NorthStar Healthcare Holdings UC and was last updated in September 2018.*
FDA Label Image

Spl-paliperidone-lable-3 (Spl Paliperidone Lable 3)

Spl-paliperidone-lable-3 (Spl Paliperidone Lable 3)
This is a description of Paliperidone, an extended-release tablet used for treating mental/mood disorders. The tablets should be swallowed whole, and not divided, crushed, or chewed. One tablet should be taken once a day. The label belongs to NorthStar Healthcare Holdings UC, and it was created in September 2018.*
FDA Label Image

Spl-paliperidone-lable-4 (Spl Paliperidone Lable 4)

Spl-paliperidone-lable-4 (Spl Paliperidone Lable 4)
This is a label for Paliperidone Extended-Release tablets, with NDC number 16714-869-01, manufactured by NorthStar Healthcare Holdings UC. Each bottle contains 30 tablets, and the medication should be taken once per day. It is important to swallow the tablets whole and not divide, crush, or chew them. No other information is available.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.